324 related articles for article (PubMed ID: 31741221)
1. Update on Menopausal Hormone Therapy for Fracture Prevention.
Stepan JJ; Hruskova H; Kverka M
Curr Osteoporos Rep; 2019 Dec; 17(6):465-473. PubMed ID: 31741221
[TBL] [Abstract][Full Text] [Related]
2. The role of menopausal hormone therapy in the management of osteoporosis.
de Villiers TJ
Climacteric; 2015; 18 Suppl 2():19-21. PubMed ID: 26474003
[TBL] [Abstract][Full Text] [Related]
3. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
4. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
5. Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study.
Ran SY; Yu Q; Chen Y; Lin SQ
Climacteric; 2017 Aug; 20(4):391-396. PubMed ID: 28523945
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy for the management of osteoporosis.
Gosset A; Pouillès JM; Trémollieres F
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101551. PubMed ID: 34119418
[TBL] [Abstract][Full Text] [Related]
7. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
[TBL] [Abstract][Full Text] [Related]
8. The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.
Komm BS; Morgenstern D; A Yamamoto L; Jenkins SN
Expert Rev Clin Pharmacol; 2015; 8(6):769-84. PubMed ID: 26482902
[TBL] [Abstract][Full Text] [Related]
9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
Cobin RH; Goodman NF;
Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of osteoporosis with hormone replacement therapy.
Christiansen C
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
Whittington R; Faulds D
Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
[TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
Pfeilschifter J
Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
[TBL] [Abstract][Full Text] [Related]
13. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Barry MJ; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW
JAMA; 2017 Dec; 318(22):2224-2233. PubMed ID: 29234814
[TBL] [Abstract][Full Text] [Related]
14. What the future holds for women after menopause: where we have been, where we are, and where we want to go.
Lobo RA
Climacteric; 2014 Dec; 17 Suppl 2():12-7. PubMed ID: 25032478
[TBL] [Abstract][Full Text] [Related]
15. Osteocytes and Estrogen Deficiency.
McNamara LM
Curr Osteoporos Rep; 2021 Dec; 19(6):592-603. PubMed ID: 34826091
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy.
Compston JE
Baillieres Clin Rheumatol; 1997 Aug; 11(3):583-96. PubMed ID: 9367038
[TBL] [Abstract][Full Text] [Related]
17. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.
Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715
[TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and bones after menopause: a reappraisal of data and future perspectives.
Anagnostis P; Bosdou JK; Vaitsi K; Goulis DG; Lambrinoudaki I
Hormones (Athens); 2021 Mar; 20(1):13-21. PubMed ID: 32519298
[TBL] [Abstract][Full Text] [Related]
20. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]